Stock Analysis
Smith & Nephew plc (SNN) Stock Analysis
Smith & Nephew plc (SNN) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Smith & Nephew plc (SNN) currently has an AIQ Score of 70/100, indicating a bullish setup. Value is the strongest factor at 79/100. Momentum is the weakest current factor at 60/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
SNN at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $30.32 |
| AIQ Score | 70/100 |
| Overall View | Bullish |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $13.46B |
| P/E Ratio (TTM) | 20.02 |
| Forward P/E | — |
| EPS (Q2 FY2026) | $0.72 |
| Revenue (Q2 FY2026) | $3.1B |
| Dividend Yield (TTM) | 2.55% |
| Beta | 0.29 |
| Volume | 1.22M |
| 52-week range | $26.12-$37.09 |
| RSI 14 | 61.44 |
| 50-Day SMA | $28.73 |
| 200-Day SMA | $30.96 |
| Analyst Price Target | $33.88 |
| Next Earnings | Mar 1, 2027 |
SNNSmith & Nephew plc
Healthcare / Medical - Devices
Leader
Strong Relative Position
Latest quote
- Momentum60
- Value79
- Quality73
- Risk resilience75
- Sentiment—
SNN Stock Analysis Summary
Smith & Nephew plc (SNN) currently has an AIQ Score of 70/100, indicating a bullish setup. Value is the strongest factor at 79/100. Momentum is the weakest current factor at 60/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bullish regime, SNN has AIQ Score of 70/100 with Value base of 79/100 and fading Momentum at 60/100. Wait for component alignment before adding exposure.
Healthcare · -0.62% stock move · SNN classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is SNN Bullish or Bearish Right Now?
SNN currently has a bullish overall setup. Value is the strongest factor at 79/100, while Momentum is weakest at 60/100. The current evidence suggests a constructive setup.
- - Quality is supportive at 73/100.
- - Risk Resilience is supportive at 75/100.
- - Price is +8.88% above its 50-day SMA.
- - Analyst target implies +11.74% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (36 vs 2).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
SNN's Technical Analysis Consensus is currently Strong Buy, with 36 buy, 8 neutral, and 2 sell votes. SNN's 14-day RSI is 61.44, which places the stock in a constructive momentum range. SNN's beta is 0.29, indicating lower market sensitivity than the broad market.
What Changed in SNN?
The largest recent change in SNN is Momentum moving down by 2.0 points over the available 7-day comparison window. Value remains the strongest visible factor.
What Would Change the SNN Outlook?
The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
SNN Decision Framework
Public evidence layers, setup checks, and risk context for Smith & Nephew plc.
Smith & Nephew plc (SNN) Stock Analysis
Smith & Nephew plc has an AIQ Score of 70/100 in a Bullish regime. Value is strongest at 79/100. Beta is 0.29, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | SNN is in a Bullish AIQ regime with score 70/100. |
| Signal Conflict | The primary conflict is that value leads at 79/100 while momentum lags at 60/100. |
| Factor Evidence | Momentum 60/100 · Value 79/100 · Quality 73/100 · Risk 75/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 79/100.
Momentum is 60/100 and RSI (14) is 61.4.
SNN is in a Bullish regime at 70/100.
Risk factor is 75/100 with beta 0.29 and annual volatility 27.3%.
Current conflict: value leads at 79/100 while momentum lags at 60/100.
SNN Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
SNN Fundamentals
SNN valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
SNN Technical Analysis
SNN technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
SNN Stock Catalysts
Track SNN earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
SNN Dividend Analysis
SNN dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
SNN Financial Data
SNN revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
SNN Risk Analysis
SNN volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
SNN Stock News
SNN stock news, market tone, recent headlines, and catalyst context.
SNN vs Medical - Devices Peers
Current peer cohort: SNN · TNDM · UFPT · ATEC · AXGN. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| SNN Current stock | 70/100 | 79/100 | 60/100 | 75/100 | -0.2 | 27.30% | Current |
| TNDM Tandem Diabetes Care, Inc. | 55/100 | 64/100 | 59/100 | 38/100 | 0.49 | 75.74% | SNN vs TNDM |
| UFPT UFP Technologies, Inc. | 68/100 | 61/100 | 81/100 | 56/100 | 0.69 | 50.83% | SNN vs UFPT |
| ATEC Alphatec Holdings, Inc. | 48/100 | 61/100 | 47/100 | 28/100 | -0.94 | 78.93% | SNN vs ATEC |
| AXGN AxoGen, Inc. | 65/100 | 33/100 | 82/100 | 55/100 | 1.61 | 61.27% | SNN vs AXGN |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for SNN: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 19, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 27, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching SNN
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for SNN
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
SNN Stock FAQ
What is SNN stock price today?
Smith & Nephew plc's current stock price is $30.32. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is SNN bullish or bearish right now?
SNN's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is SNN's market cap?
SNN's market cap is $13.46B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is SNN's current P/E ratio?
SNN's current P/E ratio is 20.02 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is SNN's RSI?
SNN's 14-day RSI is 61.44 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is SNN above its 50-day and 200-day moving averages?
SNN is 8.88% from its 50-day SMA and 1.03% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is SNN's next earnings date?
SNN's next earnings date is currently listed as Mar 1, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does SNN pay a dividend?
SNN's dividend yield is 2.55% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.